Bank Of America Corp Eagle Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 325,519 shares of EGRX stock, worth $1.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

325,519

Previous 325,504 -0.0%

Holding current value

$1.39 Million

Previous $1.71 Million 6.86%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.34 - $5.6 $50 - $84	15 Added 0.0%	325,519 $1.82 Million
Q1 2024 May 15, 2024	BUY	$4.26 - $6.51 $590,205 - $901,934	138,546 Added 74.11%	325,504 $1.71 Million
Q4 2023 Feb 14, 2024	BUY	$4.63 - $15.21 $806,194 - $2.65 Million	174,124 Added 1356.74%	186,958 $977,000
Q2 2023 Aug 14, 2023	SELL	$17.74 - $31.87 $5.42 Million - $9.73 Million	-305,340 Reduced 95.97%	12,834 $249,000
Q1 2023 May 12, 2023	BUY	$25.06 - $34.09 $6.95 Million - $9.45 Million	277,192 Added 676.37%	318,174 $9.03 Million
Q4 2022 Feb 10, 2023	BUY	$24.98 - $39.77 $135,941 - $216,428	5,442 Added 15.31%	40,982 $1.2 Million
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $852,097 - $1.52 Million	32,252 Added 980.9%	35,540 $939,000
Q2 2022 Aug 12, 2022	SELL	$41.26 - $51.35 $44,230 - $55,047	-1,072 Reduced 24.59%	3,288 $146,000
Q1 2022 May 16, 2022	SELL	$44.58 - $52.6 $3.94 Million - $4.65 Million	-88,332 Reduced 95.3%	4,360 $215,000
Q4 2021 Feb 08, 2022	BUY	$45.82 - $56.9 $1.32 Million - $1.64 Million	28,873 Added 45.24%	92,692 $4.72 Million
Q3 2021 Nov 15, 2021	BUY	$43.79 - $55.78 $147,835 - $188,313	3,376 Added 5.59%	63,819 $3.56 Million
Q2 2021 Sep 13, 2021	BUY	$36.86 - $44.5 $2.23 Million - $2.69 Million	60,443 New	60,443 $2.59 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

9.89M

Call Options Held

1.01M

Put Options Held

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $55.7M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Eagle Pharmaceuticals, Inc. Transaction History